CORTICOSTEROID CLAS S I STRUCTUR AL CLASS SUPER POTENT GENERIC NAME Betamethasone dipropionate !

"o#etaso" propionate CONCENTRATI ON 0,05 % 0,05 % PREPARAT E G O G O ! $ % MERK Oviskin (O $orderm (! & 'er()m (! & Ikaderm (!,O & !"oderma (!,O & %otas#at (!,O & Psoriderm (! & Tempovat(! , , , /etonate & Oviskin& Proto(ort& S(anderma& Ski0on , Inerson (O & P3derma (! & Top(ort(! , , Inter(on& /esone , ,

*i+"orasone dia(etate 'a"o#etaso" propionate II 'IG' POTENT -m(inonide Betamethasone dipropionate *eso1imethasone

0,05 % 0,05 % 0,. %

O ! O O ! G ! O ! G O S ! O ! % ! (Non,

0,05 % 0,05 % 0,25 % 0,05 % 0,. % 0,. % 0,. %

$")(inonide 'a"(inonide /ometason +)roate III UPPER , /I* , STRENGT' -m(inonide Betamethasone

0,05 %

dipropinate Betamethasone va"erate *eso1imethasone *i+"orasone diasetate $")ti(asone propionate 'a"(inonide Triam(ino"one I4 /I* 5 STRENGT' Betamethasone va"erate $")(ino"one a(etonide $")andreno"ide '3drokortisone va"erate /amethasone +)roate

0,. % 0,05 % 0,05 % 0,005% 0,. % 0,. % 0,.2 % 0,025% 0,05 % 0,2 % 0,. %

dipro"ene O ! ! O O S O $ O O O !

, %erskin , , , , , , , , I+"a(ort& Inter(on& /e+)rosan& /esone& /eta+"am& /o+)"e1& /omet& /otaderm 6ena(ort,- , /o+)"e1& /o"ason , , , , ,

Triam(ino"one 4 %O7ER , /I* , STRENGT' Betamethasone dipropiate Betamethasone va"erate $")(ino"one a(etonide $")ti(asone propionate $")andreno"ide '3dro(ortisone #)tirate '3dro(ortisone va"erate

0,.

! % ! ! ! ! ! !

0,05 % 0,. % 0,025% 0,05 % 0,05 % 0,. % 0,2 %

4I

%O7 POTENT

-"(ometasone dipropionate Betamethasone va"erate *esonide $")(ino"one a(etonide '3dro(ortisone a(etate

0,05 % 0,. % 0,05 % 0,0. % 0,5 %

! O % ! % O ! S ! % O

Prederm (! , N)+apo"ar (! , , '3dro(ortisone .% , , , , ,

4II

%E-ST POTENT

. % ! O $ '3dro(ortisone 0,25 % ! % h3dro("oride 0,5 % ! % O S . % ! % O S 2 % % 2,5 % ! % O S ! 8 (ream, $ 8 +oam, G 8 9e", % 8 "otion, O 8 ointment, S 8 so")tion Re+eren(e : .; /eds(ape;(om; Topi(a" !orti(osteroid; 20..; 2; /I/S Indonesia Tenth Edition; 20.0<20..;

CORTICOSTEROID CONVERSION CLASS I ACTING Short, Intermediat AGENT '3dro(ortison e ANTI -INFLAMMAT ORY . TOPICAL . SALT EQUIVALE RETAINING NT ORAL DOSE . 20 FORM AVAILABLE Ora", in=e(tion,

e -(tin9 !ortisone Prednisone Predniso"one /eth3", predniso"one /eprednisone II Intermediat e -(tin9 Triamsino"one Paramethaso ne $")predniso"o ne III %on9 -(tin9 Betamethaso ne *e1amethaso ne 0,> ? 5 5 5 5 .0 .5 25,?0 @0 0 0 ? 5 , 5 , A .0 .0 0 0 0,> 0,@ 0,@ 0 0 0 0 0 0 0 250 20 25 5 5 ? ? ? 2 .,5 0,B 0,A5 2 ,

topi(a" Ora" Ora" Ora", in=e(tion Ora", in=e(tion Ora", in=e(tion Ora", in=e(tion topi(a" Ora", in=e(tion Ora" Ora", in=e(tion topi(a" Ora", in=e(tion, topi(a" Ora" In=e(tion, pa"ets

$")dro(ortison .0 e *e1o13(ortiso 0 ne

Re+eren(e : .; 6at0)n9 B G; 2005; Basi( and !"ini(a" Pharma(o"o93 Tenth Edition; NeC Dork : /(;GraC'i"";